Studies Open Not Enrolling or Completed

A Clinical Evaluation of the GORE TAG Thoracic Endoprosthesis in the Primary Treatment of Descending Thoracic Aortic Aneurysms
Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms, IP 031 – The VALOR Trial (Medtronic Vascular)
VALOR II: The Valiant Thoracic Stent Graft System Clinical Study. Evaluation of the clinical performance of the Valiant Thoracic Stent Graft System in the treatment of descending thoracic aneurysms of degenerative etiology in subjects that are candidates for endovascular repair. (Medtronic Vascular)
Evaluation of the GORE Conformable TAG Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection
PRICELESS: Pressure and Imaging-using the CardioMEMS Endosure Sensor for Long-term follow-up after EVAR with standard surveillance. (Prospective Registry) (CardioMEMS-Inc)
Endurant Stent Graft System US Clinical Study (Medtronic Vascular, Inc)
THRIVE: Descending thoracic aortic aneurysm repair post approval study (Medtronic Vascular, Inc.)
CHAMPION: "CardioMEMS Heart Sensor allows Monitoring of Pressure to Improve Outcomes in NYHA Class III heart failure patient” (CardioMEMS, Inc)
Prospective Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM™ for Pericardial Closure
CAP STOPS LSP-AF “Feasibility Study For Safety and Efficacy Evaluation of the Combined Ablation Procedure For The Treatment of LongStanding Persistent Atrial Fibrillation” (nContact Surgical, Inc.)
CAP STOPS AF “Feasibility Study for Safety and Efficacy Evaluation of the Combined Ablation Procedure for the Treatment of Drug Refractory SympTOmatic ParoxySmal Atrial Fibrillation” (nContact Surgical, Inc.)
Sternal Plating Study (Biomet)
The HeartMate II LVAS Pivotal Study (Thoratec) Destination therapy
Clinical Investigation of the Excel – VR Pulse Generator (Cardiac Pacemakers, Inc.)
Comparison of the Hemodynamic Performance of Direct Cardiomyoplasty in an Intracoronary Adriamycin Induced Animal Model of Congestive Heart Failure (Baptist Memorial Healthcare Foundation)
Early Thrombosis of Arterialized Vein Grafts and Its Effect on Endothelial Prostacyclin & cGMP Production (University of Tennessee, Department of Surgery)
Medtronic Dynamic Cardiomyoplasty – Skeletal Muscle Assist Randomized Trial (C-SMART) Phase III (Medtronic, Inc. and Baptist Memorial Healthcare Foundation)
A Comparative Assessment of the Hemashield Microvel Double Velour Vascular Graft vs. the Goretex PTFE Vascular Graft for Above Knee Femoropopliteal Bypass in Humans (Meadox Medicals, Inc.)
A Prospective Evaluation of the Meadox VANGUARD and PASSAGER Endoprostheses for Elective Treatment of Infra-renal Abdominal Aortic Aneurysms and Aorto-Iliac Aneurysms in Humans (Boston Scientific Corporation, formerly Meadox Medicals)
High Risk Protocol: Use Of The VANGUARD and PASSENGER Endoprostheses For The Elective Treatment of Infra-Renal Abdominal Aortic Aneurysms And Aorto-Iliac Aneurysms In A Population That Is At High Risk For Open Surgical Procedures (Boston Scientific Corporation)
A Long-Term Follow-Up of the Boston Scientific Medi-tech VANGUARD I and II Endoprosthesis Systems for Elective Treatment of Infra-Renal Abdominal Aortic Aneurysms and Aorto-Iliac Aneurysms in Humans (Boston Scientific Corporation)
A Phase 3, Single-Blind, Randomized, Parallel-Group, Multicenter, Controlled Study of the Effectiveness of 2.7-g PFC/kg of Perflubron-Based Emulsion (AF0144) to Augment Intraoperative Autologous Donation and Avoid Transfusion of Allogeneic Red Blood Cells in Patients Undergoing Primary Coronary Artery Bypass Graft Surgery under Cardiopulmonary Bypass (Alliance Pharmaceutical Corp., Baptist Memorial Healthcare Foundation)
A Randomized, Open-Label Preference Study of Gengraf Compared to Neoral in Stable Solid-Organ Transplant Subjects (The PREFER Study)
ICEM 2000 EMBOL-X Intra-Aortic Filtration System Clinical Study (Randomized) (EMBOL-X, Inc.)
A Study of the Safety and Efficacy of TP10 (SCRI) in the Prevention of Post Cardiopulmonary Bypass Syndromes in Adults (Avant Immunotherapeutics, Inc.)
A Double-Blind, Placebo-Controlled, Multinational Trial to Investigate the Effect of IV Treatment with the Na+/H+ Exchange Inhibitor Cariporide (HOE642) on All-Cause Mortality and Non-fatal Myocardial Infarction in Patients at Risk of Myocardial Necrosis During and After Coronary Artery Bypass Graft (CABG) Surgery (Aventis Pharmaceuticals, Inc.)
Clinical Protocol for a Double-Blind Multicenter Study of the Safety and Efficacy of Parecoxib Followed by Valdecoxib Compared to Placebo for Treatment of Post-Surgical Pain in Patients who Have Coronary Bypass Graft via Median Sternotomy, Protocol #PARA-0505-071 (Pharmacia)
Emergency Use of the TALENT Endoluminal Spring Stent-Graft System in High Surgical Risk Patients with Abdominal Aortic Aneurysms (Medtronic Vascular)
A Phase III Randomized, Parallel, Double-Blind, Multi-Center, Placebo-Controlled Study of the Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery with Cardiopulmonary Bypass, Protocol #2000099 (Alexion Pharmaceuticals, Inc. and Procter & Gamble Pharmaceuticals)
Comparison of Primary Patency between GORE-TEX® PROPATEN Vascular Grafts and Thin Walled GORE-TEX® Stretch Vascular Grafts, PPT 01-04 (W. L. Gore & Associates, Inc.)
A Non-randomized Clinical Trial of the On-X Prosthetic Heart Valve vs. the St. Jude Mechanical Valve (Medical Carbon Research Institute)
Destination Therapy Registry (Thoratec)
TLC-II Home Discharge Registry (Thoratec)
A Phase 2, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Human Recombinant Soluble Compliment Receptor Type 1 (TP10) in Adult Women Undergoing Cardiopulmonary Bypass Surgery, Protocol #TP10-ACS-002 (Avant Immunotherapeutics, Inc.)
Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of 2mg/kg Bolus plus 24-Hour 0.05mg/kg Infusion of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass (Alexion Pharmaceuticals, Inc. and Proctor & Gamble Pharmceuticals) (PRIMO)
Save the Nephron (post heart transplant study) (Hoffmann-LaRoche, Ltd)
The HeartMate II LVAS Pivotal Study (Thoratec) Bridge To Transplant
Positive Impact of Endo Vascular Options for Treating Aneurysms Early (The PIVOTAL Study) (Medtronic Vascular; The Cleveland Clinic)
MOMENTUM: Multicenter Trial of the Orqis Medical Cardiac Recovery System for the Enhanced Treatment of CHF Unresponsive to Medical Therapy (Orqis Medical Corporation)
The EXACT Study – Emboshield and Xact Post Approval Carotid Stent Trial (Abbott Vascular Devices)
MEND CABG II: A randomized, double-blind, placebo-controlled, multi-center study to evaluate the cardio protective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft (CABG) surgery (Medicure International Inc.)
PEERLESS: Prospective Evaluation of Elastic Restraint to lessen the Effects of Heart Failure Trial (Paracor)
Aortic Valve Sixing Clinical Evaluation (Edwards Life Sciences)
Choice: Carotid Stenting for High Surgical-Risk Patients; Evaluating Outcomes Through The Collection of Clinical Evidence" (Abbott)